Emma Bickford Decourcy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1068 Putnam Pike, Chepachet, RI 02814 Phone: 401-568-6043 |
Mr. Walter Michael Watts, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1068 Putnam Pike, Chepachet, RI 02814 Phone: 401-568-6043 Fax: 401-568-7563 |
Danielle Jacquart Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1068 Putnam Pike, Chepachet, RI 02814 Phone: 401-568-6043 |
News Archive
The gap between the proportion of black and white Americans with asthma who took an inhaled or oral medicine daily to prevent attacks grew wider between 2003 and 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Daiichi Sankyo, Inc. today announced a co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol) in the US, in line with the Daiichi Sankyo strategy to expand its US portfolio through strategic alliances, in addition to internal R&D and acquisitions.
Somnambulism - otherwise known as sleepwalking - is a phenomenon which has fascinated the public and neurologists for decades, but a lot of what causes it remains a mystery.
Patients with Parkinson's disease who undergo deep brain stimulation (DBS)—a treatment in which a pacemaker-like device sends pulses to electrodes implanted in the brain—can expect stable improvement in muscle symptoms for at least three years, according to a Department of Veterans Affairs study appearing in the most recent issue of the journal Neurology.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced a poster presentation of its lead product candidate Azixa (verubulin, MPC-6827) at the 2010 Society for Neuro-Oncology Scientific Meeting and Education Day in Montreal, Canada.
› Verified 8 days ago